Issue 53, 2015

Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)

Abstract

Herein we report the use of next generation maleimides (NGMs) for the construction of a potent antibody–drug conjugate (ADC) via functional disulfide bridging. The linker has excellent stability in blood serum and the ADC, armed with monomethyl auristatin E (MMAE), shows excellent potency and cancer cell selectivity in vitro.

Graphical abstract: Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)

Supplementary files

Article information

Article type
Communication
Submitted
28 Apr 2015
Accepted
29 May 2015
First published
01 Jun 2015
This article is Open Access
Creative Commons BY license

Chem. Commun., 2015,51, 10624-10627

Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)

J. P. M. Nunes, M. Morais, V. Vassileva, E. Robinson, V. S. Rajkumar, M. E. B. Smith, R. B. Pedley, S. Caddick, J. R. Baker and V. Chudasama, Chem. Commun., 2015, 51, 10624 DOI: 10.1039/C5CC03557K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements